Table 1.
Baseline characteristics of the study patients (n = 133).
| Variable | MACE (n = 39) | Non-MACE (n = 94) | p Value |
|---|---|---|---|
| Clinical profile | |||
| Male sex (%) | 74.2% | 57.5% | 0.088 |
| Age (years) | 52.3 ± 10.0 | 52.7 ± 10.3 | 0.846 |
| Height (m) | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.656 |
| Weight (kg) | 70.5 ± 13.8 | 69.6 ± 15.9 | 0.751 |
| BMI (kg/m2) | 25.7 ± 3.9 | 25.6 ± 5.3 | 0.953 |
| Heart rate | 73.8 ± 14.2 | 71.3 ± 13.2 | 0.350 |
| SBP (mmHg) | 125.3 ± 19.5 | 131.9 ± 21.1 | 0.087 |
| DBP (mmHg) | 73.0 ± 11.7 | 76.4 ± 10.2 | 0.116 |
| Smoking | 53.8% | 42.5% | 0.316 |
| Comorbidities | |||
| Hypertension | 47.3% | 45.0% | 0.956 |
| DM | 23.7% | 20.0% | 0.813 |
| Angina | 36.6% | 32.5% | 0.802 |
| MI | 36.6% | 32.5% | 0.802 |
| DCM | 16.1% | 10.0% | 0.512 |
| Myocarditis | 2.2% | 5.0% | 0.742 |
| CAD | 35.5% | 32.5% | 0.894 |
| Medications | |||
| DM drugs | 16.1% | 20.0% | 0.771 |
| Anti-platelets | 39.8% | 37.5% | 0.957 |
| Statins | 23.7% | 17.5% | 0.576 |
| Thrombolytic agents | 6.5% | 0.0% | 0.235 |
| Antiarrhythmic drugs | 14.0% | 10.0% | 0.729 |
| Diuretics | 39.8% | 30.0% | 0.381 |
| Calcium channel blockers | 10.8% | 7.5% | 0.794 |
| Beta blockers | 68.8% | 62.5% | 0.611 |
| ACEI/ARB | 68.8% | 57.5% | 0.289 |
| Vasodilators | 16.1% | 5.0% | 0.139 |
| Iron supplements | 5.4% | 2.5% | 0.781 |
| Laboratory data | |||
| AST (U/L) | 31.4 ± 28.5 | 27.9 ± 24.3 | 0.556 |
| ALT (U/L) | 28.1 ± 16.5 | 39.8 ± 49.3 | 0.187 |
| HDL (mg/dL) | 43.5 ± 12.4 | 43.5 ± 12.1 | 0.988 |
| VLDL (mg/dL) | 30.3 ± 15.7 | 28.6 ± 13.0 | 0.598 |
| LDL (mg/dL) | 106.2 ± 53.2 | 109.7 ± 38.4 | 0.737 |
| Total cholesterol/HDL | 5.1 ± 5.3 | 4.4 ± 1.1 | 0.449 |
| LDL/HDL | 2.8 ± 1.2 | 2.7 ± 1.0 | 0.663 |
| Total cholesterol (mg/dL) | 189.3 ± 49.4 | 185.2 ± 35.7 | 0.672 |
| Triglyceride (mg/dL) | 165.5 ± 129.1 | 151.2 ± 86.2 | 0.564 |
| Non-HDL (mg/dL) | 145.8 ± 45.0 | 141.7 ± 35.4 | 0.662 |
| Glucose (mg/dL) | 113.2 ± 31.2 | 123.5 ± 51.2 | 0.210 |
| HbA1c (mg/dL) | 6.2 ± 1.2 | 6.4 ± 1.6 | 0.421 |
| TIBC (ug/dL) | 377.9 ± 85.8 | 346.7 ± 52.2 | 0.413 |
| Troponin (ng/mL) | 2.0 ± 8.9 | 0.3 ± 0.7 | 0.428 |
| BNP (pg/mL) | 342.9 ± 583.0 | 450.4 ± 569.7 | 0.470 |
| Neutrophil count (%) | 62.7 ± 12.6 | 57.5 ± 12.4 | 0.078 |
| Hemoglobin (g/dL) | 14.4 ± 3.5 | 13.5 ± 1.5 | 0.129 |
| MCV (fl) | 87.7 ± 6.7 | 86.4 ± 8.0 | 0.322 |
| MCH (pg) | 29.6 ± 2.7 | 29.0 ± 3.1 | 0.240 |
| MCHC (%) | 33.7 ± 1.0 | 41.0 ± 47.5 | 0.337 |
Note—Categorical data are expressed as numbers (%), whereas continuous variables are given as means ± standard deviations unless otherwise specified. Abbreviations: BMI, body mass index; CAD, coronary artery disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; MACE, major adverse cardiac events; DM, diabetes mellitus; MI, myocardial infarction; DCM, dilated cardiomyopathy; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; AST, aspartate aminotransferase; ALT, alanine transaminase; HDL, high-density lipoprotein; VLDL, very-low-density lipoprotein; LDL, low-density lipoprotein; TIBC, total iron-binding capacity; BNP, B-type natriuretic peptide; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.